How to Detect Additives in Cosmetics Amongst Ever Changing Regulations

Jul 14, 2017 | Blogs, Environmental / Industrial | 0 comments

In today’s technical blog, I’m talking about the cosmetics industry so let’s get right to it. According to a Research and Market report, “The Global Cosmetic market was $460 billion USD in 2014 and is estimated to reach 675 billion USD by 2020, growing at a rate of 6.4%.”1 The U.S. leads the pack with a reported $62 billion in revenue earned in 20162. So, what am I getting at? We know earnings are strong and consumers like their products. But the question remains, are these products that you put on your skin, hair, and ingest safe? Such is the thinking of scientists like me and other chemists who are routinely tasked with detecting minimal levels of potentially harmful ingredients in personal care products against ever-changing global regulations.Read the Tech Note >

Take the United States for example where, apart from color additives, cosmetic products do not require Food and Drug Administration (FDA) approval3. While in other regions such as the European Union and China, governments have put in place stricter regulations, prohibiting the use of hormones, antibiotics, and disinfectants in cosmetics. To enable labs to have options for meeting regulations such as these, I wanted to mention the following technical note, Use of X500R QTOF for Monitoring of Additives in Cosmetics, in which our researchers established a highly selective, high throughput method for rapid screening and quantification of prohibited drugs in cosmetics. Some of the benefits of this method include:

  • Rapid time savings
  • Scope of compounds tested
  • Single injection samples
  • Simultaneous identification and quantification

More Information on Cosmetic Regulations and Lab Testing
Labs know that industry regulations are ever changing. For example, in 2015, two U.S. senators proposed legislation to give the FDA more power to regulate cosmetics.4 More recently, the FDA proposed a limit to adding lead in lipstick to 10 parts per million (ppm), an effort supported by the Personal Care Products Council.  It’s not just the U.S. which is making efforts to monitor the cosmetics industry more closely. The Albanian Parliament too recently passed a law by the European Council Regulation no. 1223/2009.5 Additionally, the EU Cosmetics Committee recently voted for banning three more fragrance allergens.6

The point of which is that for labs such as CROs to stay in business, they must be ready for anything that comes their way. The cosmetic market may be growing, but so too is global awareness about harmful ingredients both amongst the public and manufacturers/governments are not sitting idle. The X500R QTOF System, as featured in the above technote, is a highly accurate, and affordable instrument that is sensitive enough to meet low levels of detection in the cosmetics products and fits into any lab as a benchtop product.

  1. http://www.businesswire.com/news/home/20150727005524/en/Research-Markets-Global-Cosmetics-Market-2015-2020-Market
  2. https://www.statista.com/statistics/243742/revenue-of-the-cosmetic-industry-in-the-us/
  3. https://www.fda.gov/aboutfda/transparency/basics/ucm262353.htm
  4. https://www.statnews.com/2016/09/27/cosmetics-fda-congress-safety/
  5. http://www.lexology.com/library/detail.aspx?g=920d68bd-6d8f-492d-b6ca-e0c6d4b1efc5
  6. https://chemicalwatch.com/54823/eu-cosmetics-committee-backs-fragrance-allergens-ban

 

Why SCIEX partners with experts around the world

Innovation in mass spectrometry does not happen in isolation. Some of the most impactful scientific advances emerge from highly specialized research communities – proteomics experts developing new peptide identification workflows, metabolomics researchers curating spectral databases, toxicologists building compound libraries, and biopharma scientists creating novel characterization methods.

Managing ADC characterization: The challenge of turning complexity into confidence

Unlike traditional monoclonal antibodies, ADCs combine an antibody backbone with linker chemistry and a cytotoxic payload. This multi-component architecture introduces overlapping layers of heterogeneity, including drug-to-antibody ratio (DAR) distributions, charge variants, post-translational modifications, and structural changes at both the intact and subunit levels. Across ADC development, these characteristics are considered critical quality attributes that must be characterized, understood, and monitored.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

Posted by

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network